dydrogesterone has been researched along with cyclin d1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciftci, Z; Franke, HR; Haanen, C; Kole, S; Vermes, I | 1 |
| Brinkhuis, M; Franke, HR; Jansen, GH; Vermes, I; Wolbers, F | 1 |
| Huang, XY; Liu, M; Liu, RH; Mu, YL; Wang, S; Wang, XT; Wu, YR; Zhao, N | 1 |
3 other study(ies) available for dydrogesterone and cyclin d1
| Article | Year |
|---|---|
In vitro effects of estradiol, dydrogesterone, tamoxifen and cyclophosphamide on proliferation vs. death in human breast cancer cells.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Death; Cell Division; Cell Nucleus; Cyclin D1; Cyclophosphamide; Dydrogesterone; Estradiol; Humans; Mucins; Progesterone Congeners; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Tamoxifen; Time Factors; Tumor Cells, Cultured | 2003 |
Effects of fulvestrant alone or combined with different steroids in human breast cancer cells in vitro.
Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dydrogesterone; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Hormone Replacement Therapy; Humans; In Vitro Techniques; Norpregnenes; Progestins; Receptors, Estrogen; RNA, Messenger | 2008 |
Dydrogesterone has no effect on uterine fibroids when used to prevent miscarriage in pregnant women with uterine fibroids.
Topics: Abortion, Spontaneous; Apoptosis; Cell Proliferation; Cyclin D1; Dydrogesterone; Female; Humans; Infant, Newborn; Insulin-Like Growth Factor I; Leiomyoma; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Progestins; Proto-Oncogene Proteins c-bcl-2; Receptors, Progesterone; Uterine Neoplasms | 2017 |